Mapping CNS Changes to Frovatriptan Administration in Acute Treatment of Prodrome or Preventative Treatment of Menstrual Migraine (MM).
Phase of Trial: Phase II
Latest Information Update: 26 May 2010
At a glance
- Drugs Frovatriptan (Primary)
- Indications Menstrual migraine
- Focus Pharmacodynamics
- 26 May 2010 Planned end date (May 2010) added as reported by ClinicalTrials.gov.
- 26 May 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.